Sareum Holdings PLC header image

Sareum Holdings PLC

SAR

Equity

ISIN GB00BMC3RJ87 / Valor 116566624

LSE London Stock Exchange, SETS (2026-03-27)

GBP 0.16%

Sareum Holdings PLC
UMushroom community rating:

5.00 1 votes No rating yet

NegativeNeutralPositive

About company

Sareum Holdings PLC is a clinical-stage biopharmaceutical company focused on the development of small molecule kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research and development efforts are centered on creating next-generation therapies that target specific kinases involved in disease pathways, aiming to provide more effective and targeted treatment options. Sareum leverages its expertise in medicinal chemistry and drug discovery to advance its pipeline of therapeutic candidates through preclinical and clinical stages, with the goal of addressing unmet medical needs in oncology and immunology.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

23.1%1Y

-82.9%3Y

-82.7%5Y

Performance

82.9%1Y

91.5%3Y

91.9%5Y

Volatility

29 M

Market cap (USD)

114,902

Daily traded volume (Shares)

0.27 / 0.27

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

1 votes

Performance:

3.00

Innovation:

5.00

Society:

5.00

Nature:

5.00

Lukas Mykhnenko

United Kingdom, 20 Oct 2025

potential breakthrough

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

Limes Schlosskliniken AG

Limes Schlosskliniken AG Valor: 38625581

Annual Return

-50%0%+50%

Risk level

110

-0.83%EUR 476.00

SIX

FactSet

Clearbit

Logos provided by Clearbit